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ABSTRACT 
 
Purpose: To evaluate and compare post-operative changes in prostate volume and clinical 
outcome after bipolar plasma vaporization (BPV) and conventional transurethral resection of 
the prostate (TURP).  
Patients and Methods: Consecutive series of patients undergoing BPV or TURP were 
included in this prospective, non-randomized study. Planimetric volumetry after transrectal 
three-dimensional ultrasound of the prostate was performed pre- and post-operatively after six 
weeks, six months and twelve months. Additionally, changes in clinical outcome parameters 
were assessed and compared between the groups. The reduction ratio and analysis of 
covariance were used to compare volume changes between BPV and TURP. Multiple 
regression analysis was performed to assess a possible interaction between pre-operative 
prostate volume and effect of therapy. 
Results: A total of 157 patients were included (BPV: n=68, TURP: n=89). Median 
preoperative prostate volume was 43.1ml in the BPV group and 45.9ml in the TURP group 
(p=0.43). Postoperatively, the prostate volumes decreased significantly in both groups. After 
catheter removal the relative residual prostate volume was significantly higher in the BPV 
group (66.6% vs. 60.8%; p=0.02). Thereafter significant differences were not detectable 
anymore (twelve months: 46.6% vs. 47.1%; p=0.82). Regression analysis revealed that tissue 
ablation after BPV was superior to TURP in prostates <45ml but inferior in prostates >45ml. 
All clinical outcome parameters improved significantly and were not significantly different 
between the groups. 
Conclusions: Volume reduction and short-term clinical outcome following pure BPV was 
excellent and comparable to conventional TURP. However, volume reduction seems to be 
limited in patients with larger prostates. 
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Introduction 
Transurethral bipolar plasma vaporization of the prostate (BPV) has been introduced as a 
minimally invasive treatment option for patients with lower urinary tract symptoms caused by 
prostatic bladder outlet obstruction [1]. It combines the benefits of bipolar electro-surgery 
(excellent hemostasis, irrigation with isotonic saline and use of a conventional bipolar TUR 
generator) with the advantages of tissue vaporization to reduce bleeding complications during 
and after the procedure [2]. A plasma corona on the surface of the spherical vaporization 
electrode is moved over the surface of the prostate to vaporize the tissue with simultaneous 
coagulation of deeper tissue layers. 
It has been shown that BPV is a low morbidity procedure with functional short- to mid-term 
results comparable or even superior to conventional transurethral resection of the prostate 
(TURP) [3-9]. However, long-term results following BPV, which are needed to prove the 
durability of symptom improvement and eventually non-inferiority compared to conventional 
TURP are lacking. 
The extent of prostate tissue ablation is known to have an impact on the long-term 
effectiveness of a transurethral procedure [10,11]. After tissue resection the extent of tissue 
removal can be estimated by the weight of the resected tissue. However, after tissue 
vaporization, it has to be assessed differently. Conventional biplane transrectal prostate 
volume measurements by ultrasound are not accurate enough due to the central defect in the 
prostate after transurethral surgery. Planimetric volumetry following transrectal three-
dimensional (3D) ultrasound of the prostate is a valid technique to reliably measure volume 
changes following transurethral surgery of the prostate [12,13]. 
Using this technique we have previously shown that volume reduction after greenlight laser 
vaporization is less extensive than after conventional TURP, particularly in larger prostates 
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[12]. The aim of the present investigation was to assess volume changes following BPV and 
compare them to volume changes after conventional TURP. 
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Patients and methods 
This prospective study was performed in a tertiary care academic center with consecutive 
series of patients who underwent either routine BPV or conventional TURP for prostatic 
bladder outlet obstruction. In general, patients undergoing platelet aggregation inhibition 
therapy with acetylsalicylic acid or patients with particular interest in a minimally invasive 
technique were offered to undergo BPV. Patients without platelet aggregation inhibitors were 
offered to undergo TURP. Exclusion criteria for both techniques were dual anti-platelet 
aggregation therapy or medication with oral anticoagulants. Further exclusion criteria were 
medication with 5-alpha-reductase inhibitors or known prostate cancer at the time of surgery. 
Patients were also excluded from further analysis, if prostate cancer was detected 
histologically on the TURP specimens, because the different growth characteristics of prostate 
cancer tissue compared to benign prostate tissue might affect the volumetry results of this 
study. The local ethics committee approved the study protocol and all included patients 
provided written informed consent. 
The pre-operative patient assessment included a uroflow study with measurements of the 
maximum urinary flow rate (Qmax) and post-void residual volume (PVR), the International 
Prostate Symptom Score (IPSS) with Quality of Life (QoL) assessment, a prostate specific 
antigen (PSA) test, a urinalysis and a urine culture. In case of an elevated PSA test or a 
suspicious digital rectal examination, a transrectal prostate biopsy was performed. 
Furthermore, transrectal 3D-ultrasound of the prostate was performed using a ProFocus 2202 
ultrasound scanner and a UA0513 magnetic wheel probe mover (both BK Medical, Herlev, 
Denmark). 
All procedures were performed either under general or spinal anesthesia using a SurgMaster 
UES-40 generator (Olympus Winter & Ibe GmbH, Hamburg, Germany) for BPV and a 160W 
ICC 350 generator (Erbe, Tübingen, Germany) for TURP. The procedures were performed as 
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described earlier [14,15]. The total operative time and the weight of the resected prostate 
tissue (after TURP) were recorded. 
Postoperatively, the catheter was usually removed after three days recording to institutional 
guidelines. Following catheter removal, transrectal 3D-ultrasound, uroflowmetry and PVR 
measurements were performed. 
Follow-up visits took place six weeks, six months and twelve months after the procedures. At 
every visit clinical outcome parameters (IPSS and QoL, Qmax, PVR and PSA) were assessed 
and patients were asked whether they had any symptoms of dysuria. Furthermore, transrectal 
3D-ultrasound of the prostate was performed. 
Planimetric volumetry of the prostate was performed on the generated 3D-images using the 
BK-3D view software (BK Medical) as described earlier [12]. Two investigators (BK and 
OG) performed the measurements without knowing the patients’ identities and their 
respective treatment modalities. All measurements were controlled and approved by the 
principal investigator (TH) prior to the final analysis. 
SPSS Statistics Software version 21 (IBM, Armonk, USA) and R version 2.15.3 (R 
Foundation for Statistical Computing, Vienna, A) were used for statistical analyses. Fisher’s 
exact test and Mann-Whitney U-test were used to compare nominal and continuous variables 
between the two treatment arms. Based on residual analysis, prostate volume was log-
transformed in order to obtain homoscedastic residuals. To compare volume changes between 
BPV and TURP at the different follow-up times the raw reduction ratio was calculated 
(residual prostate volume relative to preoperative prostate volume (BPV) / residual prostate 
volume relative to preoperative prostate volume (TURP)). Additionally, analysis of 
covariance (ANCOVA) was performed to adjust post-operative prostate volume changes for 
pre-operative volume is smaller for BPV (BPV is superior) and above 1 that the relative post-
operative volume is higher for BPV (TURP is superior). To assess whether the initial prostate 
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volume has an impact on the relative volume reduction and whether there is a difference 
between BPV and TURP, the relative postoperative prostate volumes 12 months after BPV 
and TURP were plotted against the initial prostate volume. A regression analysis was 
performed to compute the crossing point of the two graphs. All p-values <0.05 were 
considered statistically significant.  
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Results 
Of 157 included men 68 (43.3%) underwent BPV and 89 (56.7%) TURP. Baseline parameters 
of the two groups are displayed in Table 1a. Patients in the BPV group were more often under 
medication with platelet aggregation inhibitors. Furthermore, positive pre-operative urine 
cultures were more frequent in the BPV group, particularly in men with an indwelling Foley 
catheter. All other baseline parameters were not significantly different between the two 
groups. The pre-operative prostate volumes were also not significantly different between the 
BPV group (43.1ml) and the TURP group (45.9ml, p=0.43; Table1a). 
Table 1b summarizes intra- and peri-operative data of the two groups. Statistically significant 
differences were not detectable. In the TURP group the median resection weight was 16.3g 
(range: 5.0-67.4g). Major intra- or peri-operative complications did not occur and blood 
transfusions were not necessary in either group. 
Median duration of postoperative catheterization was 3 days in both groups (BPV: 2-13 days, 
TURP: 2-22 days). Two men in the BPV group (2.9%) and five men in the TURP group 
(5.6%) were discharged with an indwelling catheter (p=0.7). The median post-operative 
hospital-stay was 4 days (2-8 days) after BPV and 4 days (2-18 days) after TURP (p=0.3). 
Six weeks after the operation the number of men who reported persisting dysuria was rather 
high in both groups (Table 1c). At this time, patients in the BPV group had a significantly 
higher rate of urinary tract infections (17.6% vs. 2.2%; p<0.001). Subsequently, the rate of 
patient reported dysuria declined and remained low in both groups (Table 1c). 
All patients completed the pre-operative, post-operative and six week assessment. A total of 
136 patients (86.6%) and 128 patients (81.5%) were followed up for six months and twelve 
months, respectively (Online Resource 1). 
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Post-operative changes in prostate volumes and differences between BPV and TURP are 
illustrated in Table 2. At the time of catheter removal the residual prostate volume was 66.6% 
of the initial volume after BPV. Subsequently, the residual prostate volume continued to 
decrease (six weeks: 52.4%, six months: 48.2%) resulting in a relative residual prostate 
volume of 46.6% after twelve months. A comparable decrease was found in the TURP group 
with a relative residual prostate volume of 60.8% after catheter removal, 53.7% after six 
weeks, 49% after six months and 47.1% after twelve months. A significant difference 
between BPV and TURP was only found after catheter removal (raw reduction ratio: 1.10, 
p=0.019; adjusted reduction ratio: 1.08, p=0.03). Thereafter, volume reduction was in favor 
of TURP but differences between the groups were statistically non-significant (Table 2). 
Changes in relative volume reduction in relation to the initial prostate volume were calculated 
after 12 months. With increasing initial prostate volumes the residual prostate volume 
remained almost stable around 45 to 50% after BPV. After TURP the residual prostate 
volume decreased with increasing initial prostate volumes (around 50% for a 40ml prostate 
and 40% for a 80ml prostate). Regression analysis revealed a crossing point of the two graphs 
at an initial prostate volume of 45ml (95% confidence interval=34-58ml). This indicates that 
prostate volume reduction is better after BPV if the initial prostate volume is below 45ml and 
better after TURP if the volume is above 45ml (Online Resource 2). 
Table 1d summarizes the changes in clinical outcome parameters. After catheter removal all 
parameters improved significantly in both groups. A further improvement was detectable up 
to the six months follow-up examination. Subsequently the results remained stable. 
Significant differences in clinical outcome between the two groups were only transient and 
were not detectable anymore after twelve months. 
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Postoperatively, three patients in either group developed a urethral stricture (Table 1c), which 
were all treated by internal urethrotomy. Re-operations due to residual adenoma or bladder 
neck sclerosis were not necessary (Table 1c). 
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Discussion 
Our prospective investigation of post-operative changes in prostate volume revealed that BPV 
is an effective minimally invasive treatment option for patients suffering from prostatic 
bladder outlet obstruction. A prostate volume reduction of more than 50% of the initial 
prostate volume was accompanied by a statistically significant and clinically meaningful 
improvement of all investigated outcome parameters. Compared to conventional TURP there 
was no overall difference in volume reduction and improvement of clinical outcome. 
However, prostate volume reduction was different between the two procedures depending on 
the initial prostate volume. Our analysis revealed that in smaller prostates (<45ml) BPV is 
superior and in larger prostates (>45 ml) TURP is more efficient. 
It is known that extensive volume reduction of the prostate is not necessary to achieve good 
functional short-term results after transurethral prostate surgery [14]. In the past, numerous 
procedures showed excellent initial outcome but were subsequently abandoned due to high 
retreatment rates caused by residual adenoma tissue [15]. There is evidence that volume 
reduction has an impact on the durability of a procedure but it is not exactly known how much 
tissue needs to be removed to achieve long lasting symptom improvement [10,11]. 
Retreatments are almost inexistent for enucleation procedures where the entire adenoma is 
removed (e.g. open, holmium or thulium laser enucleation) [16]. In contrast, rather high 
reoperation rates have been reported after prostate vaporization using the first generation 80W 
greenlight laser. It is assumed that insufficient tissue ablation due to the low power output of 
this model is responsible for retreatment rates of up to 25% after five years [16]. It remains to 
be seen whether the increased output power of the two successor models will translate into 
lower retreatment rates. The reported reoperation rates after 120W laser vaporization were 
already 11% after a follow up of three years [17]. We have recently shown that volume 
reduction after 120W laser vaporization was significantly lower than after conventional 
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TURP [12]. The maximum power output of the laser was recently increased to 180W but 
mid-term outcome is not yet available. 
Whether the maximum power of the applied energy or the type of energy itself (laser energy 
versus bipolar electro energy) or even the type of energy deposition (resection versus 
vaporization) determines the effectiveness of a procedure is unknown. Our results indicate 
that there are no significant differences in volume reduction and clinical outcome between 
electro-vaporization and electro-resection. 
However, looking further into the details of our results, we identified important differences in 
the effectiveness of tissue ablation between BPV and TURP. The percentage of adenoma 
volume increases with growing overall prostate volume [18]. Thus one would expect that after 
efficient ablation of the adenoma, the relative residual prostate volume decreases with 
increasing initial prostate volume. In fact, the relative residual volume after TURP decreased 
constantly with increasing initial prostate volumes. In the BPV group, however, the relative 
residual prostate volume remained almost stable around 50%. The reason for this difference 
remains unclear. A potential explanation would be that significant abrasion of the 
vaporization electrode occurs during the procedure resulting in a continuous shrinkage of the 
electrode (Online Resource 3). This, in turn, makes tissue ablation slower and less efficient 
with increasing operative time and thus, might be responsible for the less extensive tissue 
ablation in larger prostates. Reduced tissue ablation in larger prostates compared to TURP 
was also found after 120W greenlight laser vaporization [12]. Similar to the changes observed 
at the vaporization electrode, degradation of the laser fiber occurred during the procedure and 
was associated with a significant decrease in power output [19]. It seems that extensive tissue 
removal in large prostates might be a limitation for vaporization techniques. Probably, more 
efficient enucleation procedures should be favored in these patients. Replacement of altered 
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BPV vaporization electrodes might be another simple, but also costly way to improve tissue 
ablation in larger prostates. 
Changes in clinical outcome after twelve months were not significantly different to those after 
TURP and comparable to the results reported by others [4,6,20-22]. However, we were not 
able to identify superiority of BPV compared to TURP [5,23]. Significant changes in prostate 
volume and clinical outcome parameters were not detectable anymore after six months. Thus, 
either for clinical evaluation or for research purposes the final assessment of the clinical 
outcome and volume changes after transurethral surgery should only be made after 
completion of the six months follow-up. Our data furthermore indicates that the change in 
serum PSA is not a reliable surrogate marker for volume changes after transurethral surgery. 
Although volume changes were not significantly different after BPV and TURP the relative 
PSA reduction was about 50% after BPV but almost 70% after TURP. Urinary tract infections 
but also differences in PSA secretion of different prostate zones might be responsible for the 
insufficient correlation of prostate volume and serum PSA [24]. The rate of postoperative 
urethral strictures after BPV was comparable with the rate reported by Geavlete and 
colleagues but reoperation rates were lower in the present investigation [7]. 
The non-randomized study design is a limitation of our study. Particularly differences in 
platelet aggregation inhibitor medication might have an impact on differences in volume 
reduction between the two groups. It is possible that awareness of anti-platelet aggregation 
medication led to more cautious tissue removal in the BPV group. However, the comparable 
overall volume reduction and the even higher reduction after BPV in the group of smaller 
prostates make a relevant bias rather unlikely. The overall dropout rate of 18.5% after twelve 
months is another limitation. However dropout rates around 20% in this elderly patient 
population are common even in studies without unpleasant transrectal ultrasound 
examinations [25]. Furthermore, dropout rates were similar in the BPV and TURP group. 
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Conclusions 
Volume reduction and short-term clinical outcome following pure BPV was excellent and 
comparable to conventional TURP. Volume reduction after BPV was superior to TURP in 
prostates <45 ml but limited in patients with larger prostates. The use of a second 
vaporization electrode or alternative procedures should be taken into consideration in these 
patients to lower the risk of retreatments with longer follow-up. 
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Legends to Online Resources (Supplementary Material) 
 
Online Resource 1: Study profile  
 
Online Resource 2: Changes in relative volume reduction (in %; y-axis) in relation to the 
initial prostate volume (ml; x-axis) 12 months after BPV (red line) and TURP (green line) 
 
Online Resource 3: The spherical vaporization electrode before the procedure (A) and after 
BPV of a 50ml prostate (B) 
 
 
